LINK WILLIAM J PHD

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$500,000.00
Insider Sells Quantity
12
Insider Sells Sum
$21.19M

Insider Activity of LINK WILLIAM J PHD

According to the SEC Form 4 filings, LINK WILLIAM J PHD, being in a position of

  1. director at RxSight, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 28250 shares for $1.4M,
    over all time since 2021-08-03, has bought 31250 shares for $500,000, and sold 28250 shares for $1.4M.

The largest purchase of all time was on 2021-08-03 and amounted to 31250 shares of RxSight, Inc. for $500,000.

The largest sale of all time was on 2020-12-01 and amounted to 50000 shares of Glaukos Corporation for $3.4M.

Biography of LINK WILLIAM J PHD

No biography is available at this moment.

2024-08-12SaleTarsus Pharmaceuticals, Inc.
TARS
director
35,000
0.0914%
$26.08$912,961+39.45%
2024-02-01SaleRxSight, Inc.
RXST
director
28,250
0.0843%
$49.67$1.4M+4.71%
2021-08-03PurchaseRxSight, Inc.
RXST
31,250
0.1633%
$16.00$500,000-22.08%
2020-12-01SaleGlaukos Corporation
GKOS
director
50,000
0.111%
$67.97$3.4M+9.4%
2019-08-21SaleEdwards Lifesciences Corporation
EW
director
8,564
0.0041%
$221.65$1.9M+1.08%
2019-08-20SaleEdwards Lifesciences Corporation
EW
director
1,650
0.0008%
$222.98$367,919+0.93%
2018-11-19SaleEdwards Lifesciences Corporation
EW
director
13,578
0.0065%
$149.92$2.04M+24.8%
2018-11-15SaleGlaukos Corporation
GKOS
54,050
0.1448%
$57.41$3.1M+12.28%
2018-11-13SaleGlaukos Corporation
GKOS
28,950
0.0822%
$58.01$1.68M+17.8%
2018-02-09SaleEdwards Lifesciences Corporation
EW
director
12,000
0.0055%
$122.24$1.47M+14.6%
2016-11-29SaleEdwards Lifesciences Corporation
EW
director
15,000
0.0071%
$84.01$1.26M+30.3%
2016-11-17SaleGlaukos Corporation
GKOS
60,000
0.1829%
$33.78$2.03M+17.12%
2016-05-31SaleGlaukos Corporation
GKOS
director
68,116
0.2054%
$23.98$1.63M+45.15%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.